Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates

Area of Science:

• Virology
• Molecular Biology
• Infectious Diseases

Background:

• Accurate Hepatitis C virus (HCV) typing is crucial for epidemiological studies and treatment strategies.
• Several molecular and serological methods exist for HCV RNA typing, but their comparative performance varies.
• Challenges in identifying specific HCV subtypes, particularly rare ones, can impact diagnostic accuracy.

Purpose of the Study:

• To evaluate and compare the performance of five different methods for rapid HCV RNA typing.
• To assess the accuracy of each method in identifying both HCV types and subtypes.
• To identify potential limitations of current typing assays, especially for less common subtypes.

Main Methods:

• Evaluation of 61 HCV isolates across five subtypes using five distinct typing methods.
• Methods included in-house type-specific PCR (core region), commercial DEIA (core region amplification/hybridization), commercial LiPA (5'-UTR amplification/hybridization), in-house RFLP (5'UTR), and commercial serotyping (NS4 region peptides).

Main Results:

• The commercial DEIA method achieved the highest correct viral type identification rate (90%).
• Type-specific PCR (82%), LiPA (80%), and RFLP (80%) showed good performance for viral type identification.
• Commercial serotyping yielded the lowest type identification rate (67%), and subtype identification was less accurate across all methods, with notable difficulties in identifying type 2 isolates (subtype 2c).

Conclusions:

• Commercial DEIA offers the most accurate rapid method for HCV RNA typing among those tested.
• Subtype identification remains a significant challenge for current assays, necessitating further method development.
• The prevalence of rare subtypes like 2c may influence the performance of existing HCV typing strategies.